HOOKIPA Pharma Inc.
HOOK
|
$0.7649
0.32%
0.91%
0
|
Health Technology
(0.0% 1d) (6.6% 1m) (5.6% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (0.58% volume)
Earnings Calendar: 2024-03-21
Market Cap: $ 73,851,546
http://www.hookipapharma.com
Sec Filling | Patents | 104 employees
HOOKIPA Pharma, Inc. engages in the development of immunotherapeutics, targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. Its product includes VaxWace and TheraT. The company was founded by Rolf Zinkernagel, Andreas Bergthaler, Lukas Flatz, Katherine Cohen, and Daniel Pinschewer in 2011 and is headquartered in New York, NY.
cancer infectious disease
add to watch list Paper trade email alert is off
Press-releases
HOOKIPA Pharma Announces Grant of Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
Published: 2024-04-16 (Crawled : 20:00) - globenewswire.com
HOOK | $0.7649 0.32% 0.91% 0
|
Health Technology
|
| O: 0.01%
H: 1.23%
C: -6.17%
award pharma nasdaq grant
HOOKIPA Pharma to Host Investor Call on HB-200 and Planned Path to Registration
Published: 2024-04-10 (Crawled : 11:00) - globenewswire.com
HOOK | $0.7649 0.32% 0.91% 0
|
Health Technology
|
| O: 1.02%
H: 1.76%
C: -2.36%
hb-200 pharma
HOOKIPA Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
Published: 2024-03-22 (Crawled : 11:00) - globenewswire.com
HOOK | $0.7649 0.32% 0.91% 0
|
Health Technology
|
| O: 3.58%
H: 0.0%
C: -5.19%
GILD | News | $66.16 -1.15% -1.16% 1.4K
|
Health Technology
|
| O: 0.03%
H: 0.16%
C: -0.68%
pharma business year financial results
HOOKIPA Pharma to Participate in Leerink Partners Global Biopharma Conference
Published: 2024-03-06 (Crawled : 12:00) - globenewswire.com
HOOK | $0.7649 0.32% 0.91% 0
|
Health Technology
|
| O: 3.0%
H: 0.0%
C: -4.27%
pharma conference biopharma global
HOOKIPA Pharma Provides Update on Business Priorities and Oncology Partnership Programs
Published: 2024-01-29 (Crawled : 13:00) - globenewswire.com
HOOK | $0.7649 0.32% 0.91% 0
|
Health Technology
|
| O: -8.4%
H: 0.73%
C: -1.85%
partnership pharma business update
HOOKIPA Pharma Appoints Mark Winderlich as Chief Development Officer to Lead Clinical Research and Development Organization
Published: 2024-01-16 (Crawled : 12:00) - globenewswire.com
MOR | $18.05 0.06% -0.11% 0
|
Health Technology
|
| O: 12.21%
H: 14.61%
C: 11.61%
HOOK | $0.7649 0.32% 0.91% 0
|
Health Technology
|
| O: 0.0%
H: 2.29%
C: -9.11%
pharma research
HOOKIPA Pharma Announces $21.25 Million Equity Investment from Gilead Sciences
Published: 2023-12-21 (Crawled : 12:00) - globenewswire.com
HOOK | $0.7649 0.32% 0.91% 0
|
Health Technology
|
| O: 78.76%
H: 11.88%
C: -14.6%
pharma sciences
HOOKIPA Pharma Announces FDA Clearance of its Investigational New Drug Application for HB-500 for the Treatment of Human Immunodeficiency Virus
Published: 2023-11-20 (Crawled : 12:00) - globenewswire.com
HOOK | $0.7649 0.32% 0.91% 0
|
Health Technology
|
| O: 4.05%
H: 1.85%
C: -6.11%
hb-500 fda pharma drug treatment clearance application virus
HOOKIPA Pharma Reports Third Quarter 2023 Financial Results and Recent Business Highlights
Published: 2023-11-09 (Crawled : 12:00) - globenewswire.com
HOOK | $0.7649 0.32% 0.91% 0
|
Health Technology
|
| O: -7.94%
H: 8.7%
C: -4.37%
GILD | News | $66.16 -1.15% -1.16% 1.4K
|
Health Technology
|
| O: -0.47%
H: 0.23%
C: -3.29%
pharma business financial
HOOKIPA Pharma Presents Positive Biomarker and Translational Data on HB-200 Monotherapy at Society for Immunotherapy of Cancer 2023
Published: 2023-11-03 (Crawled : 16:00) - globenewswire.com
HOOK | $0.7649 0.32% 0.91% 0
|
Health Technology
|
| O: 2.33%
H: 13.05%
C: 4.73%
hb-200 pharma biomarker positive cancer immunotherapy
Last 15 days Sec forms
| File Id | Form | Published Date | Transaction Date | Direction | Code | Amount Transacted | Owned Amount |
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 65% | 35% |
Top 10 Gainers
AGBA | News | $1.4 250.0% 35M
|
Finance
RWOD | $12.0 50.06% 3.9M
|
n/a
INDO | $4.9 20.1% 2.2M
|
Energy Minerals
NURO | $4.32 18.36% 66K
|
Health Technology
HUBC | $1.52 17.83% 4.7M
|
n/a
CARV 4 | $1.77 11.32% 8.5K
|
Finance
SWVL | $10.51 10.87% 40K
|
n/a
BROG | $1.23 10.81% 320K
|
Finance
PARA | $12.03 9.66% 5.8M
|
Information
ADAP | $0.98 9.08% 240K
|
Health Technology
Last 48 Hours Insiders Buying
ETST P 39000 | $0.068 4.61% 0
|
Manufacturing
|
13:30
FNLC P 1275 | $22.16 -0.36% 0.34% 1
|
Finance
|
12:30
ADMQ | $0.0532 -4.14% -40.18% 0
|
|
10:30
AXR P 2400 | $22.17 2.69% 0.0% 0
|
Finance
|
21:00
QCRH P 118 | $55.41 1.34% 1.31% 0
|
Finance
|
18:01
VUZI P 7500 | $1.26 3.28% 3.17% 3.6K
|
Electronic Technology
|
18:00
RMCF | $3.5501 0.57% 2.22% 0
|
Consumer Non-Durables
|
20:10